期刊文献+

单核细胞趋化因子-1及白介素-6在眼球穿孔伤中的表达

Expression of monocyte chemoattractant protein-1 and interleukin-6 in aqueous humor of eyes with perforating injury
原文传递
导出
摘要 【摘要】目的探讨单核细胞趋化因子-1(MCP-1)及白介素石(IL-6)在眼球穿孔伤患者房水中的表达水平及其意义。方法眼球穿孔伤30例(30只眼)作为试验组,在眼球穿孔伤行-期缝合术后10d抽取房水200μl;单纯年龄相关性白内障30例(30只眼)作为正常对照组,在行超声乳化吸出术术中抽取200μl房水。所有房水样本均用酶联免疫吸附试验(ELISA)测定MCP-1及IL-6水平。用t检验比较两组房水标本中MCP-1、IL-6浓度。结果试验组房水标本中MCP-1、IL-6浓度分别为(8103.18±1961.76)pg/ml和(161.35±37.34)pg/ml;对照组房水标本中MCP-1、IL-6浓度分别为(217.98±158.32)μg/ml和(2.48±5.19)pg/ml。试验组房水标本中MCP-1、IL-6表达水平均高于正常对照组,差异有统计学意义(MCP-1:F=31.901,P=0.000,IL-6:F=29.302,P=0.000)。结论眼球穿孔伤后房水中MCP-1和IL-6表达水平明显升高,这提示MCP-1及IL-6可能是眼球穿孔伤后眼内炎症反应及其相关并发症的重要介质,对眼球穿孔伤术后炎症和相关并发症的治疗有指导意义。 Objective To investigate the level of monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (1L-6) in the aqueous humor of patients with perforating injury of eyeball. Methods Thirty eyes of 30 patients with perforating injury of eyeball were recruited as the clinical trial group. Thirty eyes of 30 patients with age-related cataract were recruited as the control group. Aqueous humor samples were collected in the ocular trauma patients at 10 days after their first repairment. The control group underwent phacoemulsification cataract surgeries and aqueous humor was taken during the surgery. MCP-1 and IL-6 concentrations were detected by enzyme-linked immunosorbent assay (ELISA). T test was used to compare the differences of MCP-1 and IL-6 concentrations between the two groups. Results The differences were statistically significant in MCP-1 and IL-6 levels between the two groups (MCP-1 : F = 31. 901, P = 0. 000; IL-6 : F = 29. 302, P = 0. 000). Patients with perforating injury of eyeball had higher levels of MCP-1 (8103.18 ± 1961.76) pg/ml and IL-6 (161.35 ±37.34) pg/ml compared with the control group, MCP-1 (217.98 ±158.32)pg/ml and IL-6 (2.48 ±5.19)pg/ml. Conclusion Patients with perforating injury of eyeball have higher level of MCP-1 and IL-6 in the aqueous humor. These inflammatory markers may play roles in the post-operative inflammation and may be associated with complications.
出处 《中华眼外伤职业眼病杂志》 2016年第8期561-564,共4页 Chinese Journal of Ocular Trauma and Occupational Eye Disease
基金 基金项目:国家自然科学基金(81260151) 基金项目:云南省科技计划项目(2014RA009)
关键词 单核细胞趋化因子-1 白介素-6 眼球穿孔伤 MCP-1 IL-6 Perforating injury of eyeball
  • 相关文献

参考文献15

  • 1Yonekawa Y, Chodosh J, Eliott D. Surgical techniques in the management of perforating injuries of the globe [ J ]. Int Ophthal- real Clin, 2013, 53 ( 4 ): 127-137. DOI: 10. 1097/ IIO. Ob013e3182a12bO1.
  • 2Zhou Q, Xu G, Zhang X, et al. Proteomics of post-traumatic pro- liferative vitreoretinopathy in rabbit retina reveals alterations to a variety of functional proteins[ J]. Curr Eye Res, 2012,37 (4) : 318-326. DOI: 10. 3109/02713683. 2011. 635397.
  • 3Lei F, Zhang J, Zhang J, et al. A penetrating ocular injury can affect the induction of anterior chamber-associated immune devia- tion[J]. Mol Vis, 2008,14:327-333.
  • 4Hailer H, Bertram A, Nadrowitz F, et al. Monoeyte chemoattrac- tant protein-1 and the kidney[ J]. Curr Opin Nephrol Hypertens, 2016,25( 1 ) :42-49. DOI: 10. 1097/MNH. 0000000000000186.
  • 5O' Connor T, Borsig L, Heikenwalder M. CCL2-CCR2 signaling in disease pathogenesis [J].Endocr Metab Immune Disord Drug Targets, 2015, 15 (2) : 105-118. DOI : 10. 2174/187153031566 6150316120920.
  • 6Spandan UH, Toksoy A, Verhaart S, et al. High expression of chemokines Gro-alpha ( CXCL-1 ) , IL-8 (CXCL-8) , and MCP-1 (CCL-2) in inflamed human corneas in vivo[J].Arch Ophthal- tool, 2003,121 (6) : 825-831.
  • 7DOI: 10. 1001/archopht. 121. 6. 825. Chan MF, Li J, Bertrand A, et al. Protective effects of matrix metalloproteinase-12 following corneal injury[J].J Cell Sci, 2013,126 (17) :3948-3960. DOI.. 10. 1242/jes. 128033.
  • 8Ricker LJ, Kijlstra A, de Jager W, et al. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rheg- matogenous retinal detachment [ J ]. Invest Ophthalmol Vis Sci, 2010,51 (8) :4143-4150. DOI: 10.1167/iovs. 09-5057.
  • 9Mesquida M, Leszczynska A, Llorenc V, et al. Interleukin-6 blockade in ocular inflammatory diseases[J]. Clin Exp Immunol, 2014,176(3) :301-309. DOI: 10. llll/cei. 12295.
  • 10Lin P. Targeting interleukin-6 for noninfectious uveitis [ J ]. Clin Ophthalmol, 2015, 9: 1697-1702. DOI: 10. 2147/ OPTH. S68595.

二级参考文献49

  • 1惠延年,王琳,单武强,缪华.伴致密玻璃体出血的外伤后无光感眼的玻璃体手术探查[J].中华眼科杂志,1996,32(6):450-452. 被引量:24
  • 2孙进峰,张金嵩,王慧琴.复杂的开放性眼外伤的早期玻璃体切除术[J].眼外伤职业眼病杂志,2007,29(1):9-10. 被引量:10
  • 3Chan CK, Chhablani J, Freeman WR. Prognostic indicators for no light perception after open-globe injury: eye injury vitrectomy study. Am J Ophthalmol, 2012,153:777.
  • 4Feng K, Shen L, Pang X, et al. Case-control study of risk factors for no light perception after open-globe injury: eye injury vitrectomy study. Retina,2011,31 : 1988-1996.
  • 5Soni NG, Bauza AM, Son JH, et al. Open globe ocular trauma: functional outcome of eyes with no light perception at initial presentation. Retina,2013,33:380-386.
  • 6Heidari E, Taheri N. Surgical treatment of severely traumatized eyes with no light perception. Retina,2010,30:294-299.
  • 7Salehi-Had H, Andreoli CM, Andreoli MT, et al. Visual outcomes of vitreoretinal surgery in eyes with severe open-globe injury presenting with no-light-perception vision. Graefes Arch Clin Exp Ophthalmol,2009 ,247 :477-483.
  • 8Feng K, Hu YT, Ma Z. Prognostic indicators for no lightperception after open-globe injury: eye injury vitrectomy study. Am J Ophthalmo1,2011,152:654-662. e2.
  • 9Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmo1,2005 ,20 :191-197.
  • 10Arevalo JF, Garcia RA, A1-Dhibi HA, et al. Update on Sympathetic Ophthalmia. Middle East AfrJ Ophthalmol,2012,19: 13-21.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部